TOUJEO DOUBLESTAR

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: da2550ca4ee68bbf
Drug Approval Canada Name: TOUJEO DOUBLESTAR
Product Name: TOUJEO DOUBLESTAR
Status: Marketed
Status Date: 2020-02-04
Original Market Date: 2020-02-04
Din: 02493373
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 68:20.08
Atc Original: A10AE04 INSULIN GLARGINE
Atc Name: a 10 ae 04
Aig Number: 0147062002
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

INSULIN GLARGINE

300 UNIT / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

da2550ca4ee68bbf

Type

Standard